Skip to main content

Ikarian Capital, LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1778253 DALLAS, TX

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,807,250
+$2,508,972 QoQ
Shares Held
425,000
+73.1% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#51
of 215 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Derivatives in VRDN

reported options exposure · as of Dec 31, 2024
CallValue
$3,356,667
CallShares
175,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. VRDN ranks #23 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,807,250 425,000
2025-09-30 $5,298,278 245,518
2025-06-30 $6,569,887 469,949
2025-03-31 $6,671,912 494,949
2024-12-31 $3,356,667 175,100
2024-12-31 $9,008,922 469,949
2024-09-30 $4,550,000 200,000
2024-09-30 $11,374,476 499,977
2024-06-30 $36,284 2,789
2024-06-30 $13,010 1,000
2024-03-31 $3,132,539 178,900
2022-06-30 $3,471,000 300,000